Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 476 to 500 of 797

Sort by

Guidance programme: Technology appraisal guidanceRemove Guidance programme: Technology appraisal guidance filter

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Midostaurin for untreated acute myeloid leukaemia	TA523	13 June 2018	13 June 2018
Brentuximab vedotin for treating CD30-positive Hodgkin lymphoma	TA524	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy	TA525	13 June 2018	13 June 2018
Arsenic trioxide for treating acute promyelocytic leukaemia	TA526	13 June 2018	13 June 2018
Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy	TA520	16 May 2018	16 May 2018
Tocilizumab for treating giant cell arteritis	TA518	18 April 2018	18 April 2018
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen	TA515	28 March 2018	28 March 2018
Cabozantinib for treating medullary thyroid cancer	TA516	28 March 2018	28 March 2018
Brodalumab for treating moderate to severe plaque psoriasis	TA511	21 March 2018	21 March 2018
Tivozanib for treating advanced renal cell carcinoma	TA512	21 March 2018	21 March 2018
Obinutuzumab for untreated advanced follicular lymphoma	TA513	21 March 2018	21 March 2018
Autologous chondrocyte implantation using chondrosphere for treating symptomatic articular cartilage defects of the knee	TA508	7 March 2018	7 March 2018
Pertuzumab with trastuzumab and docetaxel for treating HER2-positive breast cancer	TA509	7 March 2018	7 March 2018
Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C	TA507	21 February 2018	21 February 2018
Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women	TA160	27 October 2008	7 February 2018
Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women	TA161	27 October 2008	7 February 2018
Pirfenidone for treating idiopathic pulmonary fibrosis	TA504	6 February 2018	6 February 2018
Intrabeam radiotherapy system for adjuvant treatment of early breast cancer	TA501	31 January 2018	31 January 2018
Ibrutinib for treating relapsed or refractory mantle cell lymphoma	TA502	31 January 2018	31 January 2018
Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer	TA503	31 January 2018	31 January 2018
Lenvatinib with everolimus for previously treated advanced renal cell carcinoma	TA498	24 January 2018	24 January 2018
Glecaprevir–pibrentasvir for treating chronic hepatitis C	TA499	24 January 2018	24 January 2018
Ceritinib for untreated ALK-positive non-small-cell lung cancer	TA500	24 January 2018	24 January 2018
Golimumab for treating non-radiographic axial spondyloarthritis	TA497	10 January 2018	10 January 2018
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer	TA495	20 December 2017	20 December 2017

Results per page

10
25
50
All